Le Lézard
Classified in: Business
Subjects: MAV, EXE, ECO, FVT

/R E P E A T -- Media Advisory: Infrastructure Announcement in Montebello/


MONTEBELLO, QC, Dec. 18, 2017 /CNW/ - Members of the media are invited to attend an important infrastructure announcement with Stéphane Lauzon, Member of Parliament for Argenteuil?La Petite-Nation, on behalf of the Honourable Amarjeet Sohi, Minister of Infrastructure and Communities; Alexandre Iracà, Member of the National Assembly for Papineau, on behalf of Julie Boulet, Minister of Tourism and Minister Responsible for the Mauricie Region; and Martin Deschênes, Mayor of Montebello.

 

Date:

Tuesday, December 19, 2017



Time:

11:00 a.m. 



Location:

City Hall of Montebello


550 Notre-Dame Street


Montebello, Quebec, J0V 1L0

 

Follow us on Twitter at @INFC_eng

 

SOURCE Infrastructure Canada


These press releases may also interest you

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:30
Blue Owl Capital Inc. ("Blue Owl") , a leading alternative asset manager, announced today the hiring of Alicia Gregory as a Managing Director based in Sydney.   Alicia brings over 25 years of investing experience with deep relationships and...

at 22:00
Zetrix Foundation and MY E.G. Services Berhad ("MYEG") signed a Memorandum of Understanding (MoU) with MaiCapital, a licensed virtual asset manager in Hong Kong, to collaborate on the launch of a virtual asset fund or Hong Kong virtual assets...

at 21:38
Grupo Elektra, S.A.B. de C.V. (BMV: ELEKTRA* Latibex: XEKT), Latin America's leading specialty retailer and financial services company, and the largest non-bank provider of...

at 21:30
O2Gold Inc. (NEX: OTGO.H) ("O2Gold" or the "Company") is pleased to announce that it has entered into a share exchange agreement dated March 21, 2024 (the "Agreement") with Quebec Aur Ltd., a private Ontario corporation, (the "Target") and its...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: